Valsartan

(Image: Getty/bong hyungjung)

The sartan saga: Recapping the recalls

By Maggie Lynch

After 2018 saw numerous sartan drugs recalled for possible carcinogenic impurities, in 2019, the industry kept an eye on the regulatory issues that followed and the breakthroughs that have mitigated some of the risks.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers